Technology
Samsung Galaxy Watch Ultra2 and Watch9: Life Companion on Your Wrist for Your Healthier Living
Published
3 months agoon
By
From Everyday Wellness to Effortless Health Management All-at-once with uncompromising performance and comfort
SYDNEY, July 23, 2026 /PRNewswire/ — Samsung Electronics Co., Ltd has announced the all-new Galaxy Watch Ultra2 and Galaxy Watch9,[1] delivering a new era of effortless health, where users can unlock in-depth, meaningful health insights simply by wearing them. To support 24/7 wearability, Samsung delivers powerful innovations that maximise comfort while advancing performance with the largest battery, brightest display for a Galaxy Watch ever and the cutting-edge Qualcomm Snapdragon® Elite platform.[2] Serving as the ultimate gateway to AI-driven health intelligence, this groundbreaking, premium lineup transforms health insights into personalised, actionable guidance.
“We believe AI’s most meaningful impact is helping us live healthier lives. Healthcare should be preventive so that people can manage their health in an effortless, continuous and deeply personalised way,” said TM Roh, Chief Executive Officer, President and Head of the Device eXperience (DX) Division at Samsung Electronics. “The new Galaxy Watch Ultra2 and Galaxy Watch9 represent a massive leap forward in realising Samsung’s health vision. By continuously tracking health data from the wrist, these new watches help to act as a vigilant health companion, turning daily vital signs into proactive, actionable insights and providing timely alerts.”
Galaxy Watch Ultra2 is our most powerful and advanced Galaxy Watch ever, built for extreme outdoor activities and high-performance seekers who demand long-lasting performance, reliability, precise tracking and continuous health monitoring in extreme conditions.
Galaxy Watch Ultra2’s dedicated tracking modes for outdoor sports help users excel and safely push their limits. The exclusive Trail Run[3] feature tracks detailed elevation, climbing progress and terrain impact to help you better pace yourself and reduce injury risk. It also provides real-time hydration guidance through Nutrition Alert,[4] a new addition to our existing Sweat Loss feature. By measuring your sweat loss relative to body weight, it provides guidance on when and how much to hydrate, helping you to monitor your heart health and helping you achieve your running goals.
The Galaxy Watch Ultra2 is rated IP69K, 10 ATM and EN13319 certified[5] – it’s not just dust- and water-resistant, it’s an EN13319 certified diving instrument. The moment you enter the water, it automatically tracks real-time diving data such as depth, time and water temperature right from your wrist.
To power these pro-level sports health features, Galaxy Watch Ultra2 is built with unprecedented hardware performance. It is equipped with a massive 800 mAh battery – a 35% capacity increase compared to the previous Ultra model.[6] Driven by the latest Qualcomm Snapdragon® Elite platform,[7] it establishes a new benchmark in power, speed and GPS tracking. The expanded display provides a smartwatch world-first 5,000 nits of brightness,[8] providing clear visibility even under intense sunlight.
Galaxy Watch Ultra2 retains its tough titanium casing to ensure rugged strength, while also introducing enhanced comfort and stability for a broader, more diverse range of users. Despite a larger battery,[9] Galaxy Watch Ultra2 achieves an innovative slimmer[10] design that transitions seamlessly from rugged outdoor and sports activities to everyday lifestyle use. Advanced internal re-engineering reduces the device’s thickness by 12% compared to the previous generation. Coupled with lighter and softer bands that reduce weight, Galaxy Watch Ultra2 delivers 24/7 wearability, health data tracking and exceptional comfort.
Galaxy Watch Ultra2 will be available in a 47 mm size in Titanium Silver and Titanium Grey.
Galaxy Watch9: Everyday Wellness with All-Day Comfort and Lasting Battery
Galaxy Watch9 is the ultimate everyday health companion, designed for wellness-conscious users who want to build healthier habits through effortless, continuous health tracking. By simply wearing it, this versatile watch turns personal biomarkers into actionable health insights, empowering users to effortlessly manage their daily routines and take proactive control of their long-term wellbeing.
To maximise its role as a health companion, Galaxy Watch9 is backed by powerful hardware and an incredibly comfortable design. It features a lightweight yet tough aluminium casing that preserves Galaxy Watch’s signature cushion silhouette, refined specifically for a closer, more natural fit on the wrist. Combined with a wide range of interchangeable, soft-touch bands, Galaxy Watch9 ensures unmatched all-day comfort – enabling the continuous, 24/7 wear required to capture accurate and consistent health data.
This exceptional wearability is powered by next-generation internal innovations. Driven by the new Qualcomm Snapdragon® Elite platform,[11] Galaxy Watch9 delivers a massive boost in speed and processing power for seamless, lag-free health monitoring. It is equipped with an efficient 390 mAh battery[12] that ensures dependable, around-the-clock tracking from day to night. Furthermore, a brilliant 3,000-nit display guarantees effortless readability and clear visibility under different lighting conditions, making it easy to check your health status at a glance.
Galaxy Watch9 will be available in two sizes, 40 mm and 44 mm. Galaxy Watch9 40 mm is available in Graphite and Cream, while Galaxy Watch9 44 mm is available in Graphite and Silver.
AI-Powered Health Intelligence: Comprehensive and Actionable Health Insights
At the core of Galaxy Watch Ultra2 and Galaxy Watch9 is Samsung’s AI-powered health intelligence. The advanced biosensors of each Galaxy Watch capture continuous data about a user’s lifestyle habits to develop a deep understanding of their health. Using advanced AI models, Galaxy Watch translates health insights into simple, proactive recommendations, helping users understand not just what is happening in their bodies, but what to do next.[13]
The new capabilities – available on both Galaxy Watch Ultra2 and Galaxy Watch9 – advance Samsung’s preventive care vision by combining everyday data with years of rigorous clinical research conducted with world-renowned universities and medical institutions. Built on this foundation, the Galaxy Watch helps to deliver more accurate and meaningful health guidance across key pillars including sleep, activity, cardiovascular health and recovery.
Vitals:[14] Proactively monitor your personal health baseline while you sleep and receive seamless alerts for significant deviations.Heart Health Score:[15] Gain an effortless understanding of your cardiovascular wellness through a simple, actionable score and personalised lifestyle recommendations.Daily Cardio Load:[16] Optimise your training using tailored guidance on your workout volume and estimated recovery needs.Fitness Index:[17] Uncover a holistic view of your physical strength with personalised goals to improve everyday performance.Hearing:[18] Protect your long-term hearing health with alerts for unsafe noise levels and detailed reports.
With these features, users gain access to intelligent, personalised insights that empower them to seamlessly manage their long-term wellness journey and reach their goals.
Designed for Every Lifestyle: Purpose-Built Band Collections
Your smartwatch should be as unique as you are, and both Galaxy Watch Ultra2 and Galaxy Watch9 offer a range of diverse band options to fit every lifestyle.
Because elite performance demands the right gear for the right moment, Samsung offers a specialised collection of Ultra bands. Whether you are tackling rugged terrain, swimming or heading into a business meeting, you have the flexibility to choose the perfect band tailored to your specific purpose and environment, ensuring optimal functionality without compromising on style:
The Marine Band, a light, breathable silicone band designed for all-day adventures and extreme conditions.The Peakform Band, a hybrid material band delivering a premium finish optimised for both elegance and athletic performance.The Trail Band, a classic fabric band featuring enhanced breathability and a superior fit for lasting comfort, even during demanding outdoor activities like running.
Designed with ultimate self-expression in mind, the expansive new Watch9 band collection empowers you to showcase your personal style and customise your look. Featuring innovative new materials and a vibrant spectrum of colours, these bands maximise comfort across diverse activities – from intense workouts to your everyday routines:
The Sports Band, a thin, soft all-rounder for ultimate comfort and effortless transitions from workouts to daily life.The Misty Band, crafted from premium soft silicone that securely wraps your wrist for a stable, bounce-free fit. Featuring subtle and soft two-tone colours, it delivers a sophisticated look that effortlessly complements your everyday style.The Fabric Band, a lightweight, breathable daily band offering maximum comfort – even while you sleep.
Samsung Care+: Quick Access to Diagnostics and More
To give users peace of mind after upgrading, Samsung Care+[i] offers comprehensive protection with fast repairs for accidental damage, extended warranty coverage and certified expert support at home and abroad, making it easier to stay covered wherever life takes them.
Additionally, Galaxy Watch users can manage their Samsung Care+ plan from the Warranty and care menu available on Galaxy mobile phones running on One UI 9. This is a new settings hub that gives users quick access to warranty information, self-diagnostics, repair requests, remote support and Samsung Care+ services – all from their mobile phone.
Galaxy Watch Ultra2 and Galaxy Watch9 come with exclusive subscription trial benefits:
Strava 60-Day Free Trial[19]: Users can start training with the world’s most active community, where 195 million active people across 185 countries track every effort and cheer each other on. But Strava goes beyond training – users can connect with their community and discover new running routes by tracking workouts directly on their watch, then opening the Strava app on their mobile phone. To activate a free trial, users can open the Strava mobile app, go to Settings and tap the Samsung offer.iFIT 2-Month Free Trial[20]: Users can explore global destinations with elite iFIT trainers and track workouts directly on their watch. To activate a free trial, users can open the Samsung Health app on their mobile phone and tap promotion in the Settings menu.
Availability20
Together with the new Galaxy Z series, Galaxy Watch Ultra2 and Watch9 expands Samsung’s AI ecosystem, bringing life companion experiences across every form factor, from wrist to pocket to home.
Galaxy Watch Ultra2 and Galaxy Watch9 are available for pre-order in Australia starting July 23, with general availability starting August 14.
To give users added peace of mind, Samsung Care+[21] offers certified expert support both at home and abroad with comprehensive coverage and fast repairs for accidental damages. Customers who purchase a new Galaxy Watch on Samsung.com and enrol in a monthly Samsung Care+ plan will receive the first three months of coverage at no cost.
Additionally, Galaxy Watch users can manage their Samsung Care+ plan from Warranty and care menu available on Galaxy mobile phone running on One UI 9. This is a new settings hub that gives users quick access to warranty information, self-diagnostics, repair requests, remote support and Samsung Care+ services – all from their mobile phone.
To learn more about Galaxy Watch Ultra2 and Galaxy Watch9, please visit: Samsung Australia Newsroom or Samsung.com.
About Samsung Electronics Co., Ltd.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining worlds of TVs, digital signage, smartphones, wearables, tablets, home appliances and network systems, as well as memory, system LSI and foundry. Samsung is also advancing medical imaging technologies, HVAC solutions and robotics, while creating innovative automotive and audio products through Harman. With its SmartThings ecosystem, open collaboration with partners, and integration of AI across its portfolio, Samsung delivers a seamless and intelligent connected experience. For the latest news, please visit the Samsung Newsroom at news.samsung.com.
Specifications
Galaxy Watch Ultra2
Galaxy Watch9
Colour
*Available colour may vary
by market, carrier or retailer
47mm: Titanium Silver, Titanium Grey
44mm: Graphite, Silver
40mm: Graphite, Cream
Dimensions & Weight
47mm: 47.4 x 47.1 x 10.7mm (61.5g)
44mm: 46.0 x 43.7x 8.6mm (34.0g)
40mm: 42.7 x 40.4x 8.6mm (31.5g)
Display
– 47mm: 1.52-inch (38.5 mm), 498×498
Super AMOLED, Full Colour Always On
Display, up to 5,000 nits
– 44mm: 1.47-inch (480×480)
Super AMOLED, Full Colour Always On Display
Up to 3,000 nits
– 40mm: 1.34-inch (438×438)
Super AMOLED, Full Colour Always On
Display, up to 3000 nits
Processor
Qualcomm SDW6100 (3nm Processor, 5 Core)
Memory & Storage
2GB memory + 64GB storage
2GB memory + 32GB storage
Battery
800 mAh
Up to 60 hrs (AOD On)
– 44mm : 445 mAh
– 40mm: 390 mAh
Up to 30 hrs (AOD On)
Charging
Fast Charging
Fast Charging
OS
Wear OS Powered by Samsung (Wear OS 7)
UI
One UI 9 Watch
Sensors
Samsung BioActive Sensor (Optical Bio-signal Sensor +
Electrical Heart Signal + Bioelectrical Impedance Analysis),
Temperature Sensor, Accelerometer, Barometer, Gyro Sensor,
Geomagnetic Sensor, Light Sensor,
Samsung BioActive Sensor (Optical Bio-signal Sensor +
Electrical Heart Signal + Bioelectrical Impedance Analysis),
Temperature Sensor, Accelerometer, Barometer, Gyro Sensor,
Geomagnetic Sensor, Light Sensor
Connectivity
Bluetooth / Bluetooth + LTE, Wifi, NFC,
GPS (L1+L5 Dual Frequency GPS)
Bluetooth / Bluetooth + LTE, Wifi, NFC
GPS (L1+L5 Dual Frequency GPS)
Durability & Water Resistance
10ATM+ / IP69K / MIL-STD-810H /
EN13319
5ATM + / IP68 / MIL-STD-810H
Compatibility
Android 13.0 or higher and with more than 1.5GB of memory
* Device activation is only available after connecting to a smartphone that supports Google Mobile Services.
Compatible devices may vary by market, carrier or device brand.
[1] Availability and features may vary depending on market, model and the smartphone paired. All functionality, features, specifications and other product information provided in this document including, but not limited to, the benefits, design, pricing, components, performance, availability and capabilities of the product are subject to change without notice.
[2] Snapdragon branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries.
[3] Trail Run is available on Android phones (Android 13 or above) and requires the Samsung Health app (v7.0 or above). Samsung account login required. Service only available with Galaxy Watch Ultra2.
[4] To activate Nutrition Alert, go to the exercise settings and enable the Nutrition feature. Please note that the Nutrition Alert is only supported for certain specific activities.
[5] Galaxy Watch Ultra2 has obtained EN13319 certification, which is a standard applicable to instruments measuring water depth by the environmental pressure as used by divers and also the dive time in certain condition. Water resistance is not a permanent condition and can diminish over time. If it’s been exposed to seawater, rinse it in freshwater and dry after use. Galaxy Watch Ultra2 is water resistant for 10 minutes in water with a depth of 100 metres according to the ISO22810 standard. Third party testing was conducted in 5% salty water and 4ppm chlorine water. Galaxy Watch Ultra2 has an IP69K rating based on lab test conditions, in accordance with ISO 20653 and is dust and water resistant. It can withstand water during high-pressure/steam jet cleaning at a distance of up to 150mm, with sprays at 0°, 30°, 60° and 90° for 30 seconds, per position. IPX9K does not test for diving or high pressure water activities suitability. Galaxy Watch Ultra2 has an IP68 rating based on lab test conditions and is dust resistant and water resistant for submersion in up to 1.5 meters of fresh water for up to 30 minutes. Third party testing was conducted in 5% salty water and 4ppm chlorine water. IP68 does not test for diving or high pressure water activities suitability. Galaxy Watch Ultra2 has obtained MIL-STD-810H Certification and has been tested under various specific lab conditions, including temperatures ranging from -40° C to 80° C, high altitude pressure at 15,000 ft and transit drop test at a height of 1.5 metres on a plywood surface. Actual results may vary. Refer to the user manual for further information, including care/use instructions.
[6] Galaxy Watch Ultra2 has an 800mAh capacity battery and Galaxy Watch Ultra (2025) has a 590mAh capacity battery.
[7] Snapdragon branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries.
[8] Based on market research of globally released smartwatches as of June 2026. The 5,000-nit specification refers to the localised peak brightness achieved under high ambient light and full-screen brightness may differ. Actual brightness may vary or be limited depending on environmental factors, device temperature and usage conditions.
[9] Compared to Galaxy Watch Ultra (2025). Galaxy Watch Ultra2 has an 800mAh capacity battery and Galaxy Watch Ultra (2025) has a 590mAh capacity battery.
[10] Compared to the previous Galaxy Watch Ultra.
[11] Snapdragon branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries.
[12] Galaxy Watch9 40mm has a 390 mAh battery capacity.
[13] Samsung Health is not a medical/therapeutic device. It is solely intended for fitness and wellness purposes only and is not intended for use in the diagnosis of disease or other conditions; or in the cure, mitigation, treatment or prevention of disease; or for the prevention or control of conception or pregnancy. Samsung recommends that you consult with your doctor or physician before participating in any exercise program.
[14] Vitals is available on Samsung Galaxy phones and requires Samsung Health app. Samsung Account login required. Requires initial setup wearing the Galaxy Watch for 7 out of 28 nights. Vitals is not a medical/therapeutic feature. It is solely intended for fitness and wellness purposes only and is not intended for use in the diagnosis of disease or other conditions; or in the cure, mitigation, treatment or prevention of disease; or for the prevention or control of conception or pregnancy. Samsung recommends that you consult with your doctor or physician before participating in any exercise program..
[15] Heart health is available on Android phones (Android 13 or above) and requires Samsung Health app (v7.0 or above). Samsung Account login required. Requires initial setup wearing watch for 24 hours (including awake and asleep). To calculate Heart health score, data on related lifestyle factors – including sleep duration, BMI, vascular trends and stress, and moderate to vigorous activity time – must be collected. To use this feature, you need a Galaxy Watch7 or above with One UI 9 or above. Heart health score is not a medical/therapeutic feature. It is solely intended for fitness and wellness purposes only and is not intended for use in the diagnosis of disease or other conditions; or in the cure, mitigation, treatment or prevention of disease; or for the prevention or control of conception or pregnancy. Samsung recommends that you consult with your doctor or physician before participating in any exercise program.
[16] Daily Cardio Load is available on Samsung Galaxy phones and requires Samsung Health app. Samsung Account login is required. To use the Daily Cardio Load features, at least 7 days of activity records are required, while 28 days of continuous wear is recommended for optimal accuracy. Please note that values may increase in daily situations where heart rate rises, such as during tension, anxiety, or stress. Daily Cardio Load is not a medical/therapeutic feature. It is solely intended for fitness and wellness purposes only and is not intended for use in the diagnosis of disease or other conditions; or in the cure, mitigation, treatment or prevention of disease; or for the prevention or control of conception or pregnancy. Samsung recommends that you consult with your doctor or physician before participating in any exercise program.
[17] Fitness Index on Galaxy Watch9 is available on Android phones (Android 13 or above) and requires the Samsung Health app v7.0 or above. Samsung account login required. To use the feature, BIA and VO2Max each need to be measured at least once, along with 2 days of activity records and step count data. It is solely intended for fitness and wellness purposes only and is not intended for use in the diagnosis of disease or other conditions; or in the cure, mitigation, treatment or prevention of disease; or for the prevention or control of conception or pregnancy. Samsung recommends that you consult with your doctor or physician before participating in any exercise program.
[18] To use the features, activation from the Watch is needed (Samsung Health > Hearing > Settings > Sound Monitoring “On”).
[19] STRAVA is owned and operated by Strava, Inc. Free 60-day Strava subscription trial promotion is available worldwide, excluding Belarus, China, Cuba, Iran, North Korea, Russia, Syria, sanctioned parts of Ukraine and South Korea.
[20] iFit is a trademark of iFit Health & Fitness Inc. Free 2-month iFIT subscription trial promotion is available only in the following 23 markets: Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, France, Germany, India, Ireland, Italy, Mexico, the Netherlands, New Zealand, the Philippines, Portugal, Singapore, South Africa, Spain, Switzerland, the United Kingdom and the United States.
[21] Terms and conditions apply. Samsung Care+ coverage, service type and promotion details may vary by country/region and a deductible (service fee) may apply. To be eligible for Samsung Care+ promotion benefits, registration may be required. For detailed Samsung Care+ information, please visit https://www.samsung.com/samsung-care-plus/. Care at home & abroad: When in need of Samsung Care+ services during your travel, contact the visiting country/region’s local customer services center in advance for Samsung Care+ availability.
[i] Terms and conditions apply. Samsung Care+ coverage, service type and promotion details may vary by country/region and a deductible (service fee) may apply. To be eligible for Samsung Care+ promotion benefits, registration may be required. For detailed Samsung Care+ information, please visit https://www.samsung.com/samsung-care-plus/. Care at home & abroad: When in need of Samsung Care+ services during travel, contact the visiting country/region’s local customer service center in advance for Samsung Care+ availability.
View original content:https://www.prnewswire.com/apac/news-releases/samsung-galaxy-watch-ultra2-and-watch9-life-companion-on-your-wrist-for-your-healthier-living-302833183.html
SOURCE Samsung Electronics Co., Ltd
You may like
Technology
OASE+ and Elsevier Agree Next-Phase Read and Publish Agreement to Expand Open Access Publishing in Japan
Published
6 minutes agoon
October 26, 2026By
A new three-year term removes the annual cap on open access publishing under the Read and Publish agreement and extends eligibility beyond universities
TOKYO, Oct. 26, 2026 /PRNewswire/ — OASE+ (Open Access for Scholarly Empowerment +), the collective negotiating body established with Japanese government support to advance the country’s national open access policy, and Elsevier, a global leader in advanced information and decision support, have agreed a read-and-publish agreement covering 2027 to 2029.
The agreement further develops the framework established by Elsevier in partnership with the Japan Alliance of University Library Consortia for E-Resources (JUSTICE) for 2024 to 2026. Under this framework Japanese research institutions are able to expand open access publishing at a pace suited to their individual circumstances while maintaining access to scholarly journals.
From 2027, researchers at participating institutions will be able to publish open access in eligible Core Hybrid journals, subject to the terms of the agreement and without an annual cap on the number of open access articles. The decision to publish open access will rest with the researcher and the research itself, giving researchers greater flexibility in choosing open access publishing and greater certainty in meeting their funders’ and institutions’ open access requirements.
A separate agreement applies the same approach to Cell Press. For institutions that subscribe to Cell Press Hybrid titles, reading access and open access publishing will cover the subscribed titles. The agreement will also have no annual cap on the number of open access articles and run from 2027 to 2029.
The agreement also extends eligibility for the first time beyond universities to national research and development agencies, opening participation to a substantial part of Japan’s publicly funded research base.
Japan is one of the world’s largest producers of scientific research. Wider open access publishing increases the international visibility of that research, supports collaboration across borders, and helps ensure Japanese findings inform science, practice and policy well beyond Japan. It also advances the objectives of the Japanese government’s National Policy on Promoting Open Access to Publicly Funded Scholarly Publications and Scientific Data.
The agreement follows extended discussions between OASE+ and Elsevier and reflects the findings of a survey of the needs of institutes that expressed interest in the Read and Publish agreement, as well as experience gained through the current framework.
Professor Yasuteru Shigeta of the University of Tsukuba, Chair of OASE+, said: “In 2024, OASE was established under the Japanese government’s ‘National Policy on Promoting Open Access to Publicly Funded Scholarly Publications and Scientific Data’. Through collaboration with JUSTICE, OASE has since strengthened its framework as OASE+. This enhanced structure enabled constructive negotiations with Elsevier, building upon the achievements and experience gained through the pilot proposal implemented for JUSTICE through 2026. As a result, we are pleased that researchers will be able to publish open access in Core Hybrid journals without any cap on the number of articles, and that Cell Press Hybrid journals are now also available under a Read and Publish agreement. While there should be multiple valid approaches to advancing open access, we hope that this agreement will serve as one of those pathways and help enhance the visibility of research from Japan to create positive impact.”
Gemma Hersh, Senior Vice President, Sales and Commercial Director, Primary Research, Elsevier, said: “We are delighted that this new agreement with OASE+ will enable us to further develop our long-standing partnership with the Japanese research community. We are grateful to OASE+ and the institutions that expressed interest in the agreement for the collaboration and pragmatism they brought to our discussions, and for helping to establish a framework with broader reach across Japan’s research base. Japan’s research is of global importance, and this agreement will help ensure more of it is openly available to researchers around the world.”
Further information is available from OASE+ and on Elsevier’s open access agreements page.
Notes to editors
A Read and Publish agreement combines, in a single contract, the subscription fees research institutions paid publishers for access to scholarly articles with the fees for publishing articles open access (article publishing charges, or APCs).
Core Hybrid journals are subscription-based journals that also give authors the option to publish individual articles open access. Under the 2027 to 2029 agreement, open access publishing in eligible Core Hybrid journals is available without an annual open access publishing limit.
Cell Press Hybrid journals are subscription-based Cell Press journals that also give authors the option to publish individual articles open access. A companion agreement covering 2027 to 2029 applies to Cell Press Hybrid journals, under which reading access and open access publishing are aligned to the Cell Press Hybrid journals an institution subscribes to, without an annual open access publishing limit.
Institutions that have expressed interest will not necessarily enter into the agreement immediately. Each institution reviews the terms and decides independently whether to participate, and contract commencement dates will vary. Institutions wishing to participate must submit an expression of interest through OASE+. As of October 21, 167 institutions have expressed interest in the agreement with Elsevier.
About OASE+
OASE+ (Open Access for Scholarly Empowerment +) is a team supported by the Japanese government working to establish a collective bargaining framework, led by universities and other research institutions, for negotiations with academic publishers. Through discussions with global academic publishers, OASE+ aims to contribute to the realization of the Japanese government’s National Policy on Promoting Open Access to Publicly Funded Scholarly Publications and Scientific Data.
OASE+ succeeds the activities of OASE, which was established in 2024, and operates as a joint initiative involving the Japan Alliance of University Library Consortia for E-Resources (JUSTICE) and OASE to promote open access to scholarly publications. For more information, visit the OASE+ website.
About Elsevier
Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals, and educators across 170 countries in their vital work. We help impact makers achieve better outcomes with research and clinical-grade solutions built on the world’s leading evidence-based scientific and medical content, precision AI, and expert human assessment. We champion inclusion and sustainability, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @elsevierconnect.
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/oase-and-elsevier-agree-next-phase-read-and-publish-agreement-to-expand-open-access-publishing-in-japan-302918039.html
Technology
uSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart
Published
6 minutes agoon
October 26, 2026By
SINGAPORE, Oct. 26, 2026 /PRNewswire/ — uSMART Securities (Singapore) Pte. Ltd. (“uSMART”) has announced the addition of the PIVOT- GlobalSave Portfolios Balanced Strategy to its FollowSmart platform. Managed by PIVOT Fintech Pte. Ltd. (“PIVOT”), the strategy is being made available through uSMART’s digital platform as part of the companies’ collaboration to provide investors with access to professionally managed investment strategies. Investors can find information about available strategies via the uSMART App at uSMART Securities.
Streamlining Operations for Fund Management Companies
Offering professionally managed investment strategies to a wider investor base can involve significant technology, operational and client servicing requirements. FollowSmart provides a digital workflow supporting account onboarding, trade implementation, position monitoring, valuation and client reporting. The platform is designed to help investment managers handle these operational processes while focusing on portfolio management.
Empowering Investors with a Digital Marketplace
For individual investors, FollowSmart provides a digital platform for exploring professionally managed investment strategies. Available strategies span different asset classes, global markets and risk profiles. Users can review information such as investment philosophy, historical performance and the credentials of the management team, and monitor their portfolios over time. These features may help investors assess which available strategies are relevant to their own objectives and circumstances.
The PIVOT- GlobalSave Portfolios Balanced Strategy
uSMART is acting as an authorized distributor of the PIVOT- GlobalSave Portfolios Balanced Strategy, which is managed by MAS-regulated PIVOT Fintech. The investment team is led by Victor Lye. The strategy uses a quantitative investment approach informed by Modern Portfolio Theory (MPT). It invests in U.S.-listed ETFs across equities, fixed income, commodities and real estate to build globally diversified portfolios. Asset allocation weights are adjusted in response to macroeconomic trends, with the objective of balancing expected returns and risk for medium- to long-term investors.
Expanding the FollowSmart Ecosystem
The addition of PIVOT Fintech is part of uSMART’s ongoing development of the FollowSmart platform and its network of investment managers. Other strategies recently added to the platform include the Global Quantitative Core Growth Strategy by Sunova Capital Management and the JMC Absolute Return Strategy by JMC Capital Asset Management. Together, these offerings provide investors with access to a range of professionally managed investment approaches.
About uSMART Securities (Singapore) Pte Ltd – uSMART Securities (Singapore) Pte Ltd, established on March 22, 2021, is the Singapore entity under uSMART Group (uSmart Holding Ltd.). The company holds a Capital Markets Services (CMS) Licence (Licence No. CMS101161) regulated by the Monetary Authority of Singapore (MAS). Based in Singapore, it provides financial services through the uSMART platform. Its products include US, Hong Kong, Singapore, Japan and UK stocks, options, futures, ETFs, funds, Contracts for Difference (CFDs) and forex products. Its services include trading tools, client account services, risk management arrangements and segregated client fund accounts.
About PIVOT Fintech – PIVOT Fintech Pte. Ltd. (UEN 201716150D) holds a Capital Markets Services Licence (CMS100806) regulated by the Monetary Authority of Singapore and serves as the Investment Manager of the Strategy. PIVOT’s investment team is led by its founder, Victor Lye, who has over 35 years of senior leadership experience across wealth management, insurance, fintech, and artificial intelligence. He holds a First-Class Honours Degree in Economics and Accounting from the University of Adelaide and is a Chartered Financial Analyst (CFA) and Certified Financial Planner (CFP).
Risk Disclaimer – Investment involves risks. Past performance is not indicative of future performance. Investors should carefully consider their investment objectives, financial situation and risk tolerance before making any investment decision. This material is provided for information and reference purposes only and does not constitute an offer, solicitation, recommendation or investment advice. This advertisement has not been reviewed by the Monetary Authority of Singapore.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/usmart-and-pivot-fintech-introduce-globalsave-portfolios-balanced-strategy-on-followsmart-302918647.html
SOURCE uSMART Securities (Singapore) Pte Ltd
Technology
FFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia’s Investor Weekly Report to October 26
Published
6 minutes agoon
October 26, 2026By
Faraday Future announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia has been rescheduled to October 26.FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) will hold its Listing Ceremony and Investor Day on October 26.FFR management will outline the company’s future strategic direction and business plans and engage with investors in attendance.The full event video will be available at 5:00 p.m. ET on October 26 at: https://www.ff.com/us/
LOS ANGELES, Oct. 25, 2026 /PRNewswire/ — FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) (“FFR” or the “Company”), a U.S.-listed Embodied AI (“EAI“) robotics ecosystem company, today highlighted an update from Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future” or “FF“) that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia has been rescheduled to October 26.
FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) will hold its Listing Ceremony and Investor Day on October 26, 2026. During the event, FFR management will outline the company’s future strategic direction and business plans and engage with investors in attendance.
The full event video will be available at 5:00 p.m. ET on October 26 at: https://www.ff.com/us/
About FF EAI Robotics Ecosystem Inc.
FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) (renamed from AIxCrypto Holdings, Inc. and AIXC, effective September 30, 2026) is a U.S.-based Embodied AI (EAI) robotics company that is in the process of acquiring the FF EAI Robotics business. Upon completion of the acquisition, the Company will focus on the research and development, manufacturing, commercialization, and deployment of intelligent robotic technologies, products, and industry solutions.
The Company is committed to building a “Four-Core Full-Stack” AI ecosystem covering the full lifecycle of robotics, consisting of EAI Brain & Developer Platform, EAI Devices, Industry Productivity Solutions, and EAI Data Factory. Guided by the technology and product philosophy of “One Brain, Multi-forms, Multi-capabilities,” the Company aims to empower humanoid, biomimetic, and other robotic form factors through a unified EAI Brain, while continuously expanding their multi-task and multi-scenario capabilities. The ecosystem is designed to support the full robotics lifecycle, including R&D, deployment, data collection and training, operations, and commercial applications.
The FF EAI Robotics business has already achieved commercial deliveries of humanoid and biomimetic robotic products. Through its multi-form-factor robotic products, EAI technology platform, closed-loop data capabilities, and industry solutions, the business continues to advance the scaled adoption of robotics across real-world applications. The Company also operates RoboShare, a robot-sharing and services platform designed to connect robotic assets, service capabilities, customer demand, and ecosystem partners, further strengthening its robotics commercialization and service ecosystem.
For more information, visit www.ff.com.
ABOUT FARADAY FUTURE
Founded in 2014, Faraday Future (FF) is a U.S.-based Physical AI ecosystem company dedicated to reshaping the future of robotics and mobility solutions through AI innovation and technologies. FF focuses on two major product strategies within the Embodied AI (EAI) robotics business: EAI humanoid and bionic robots, and EAI automotive-focused robots. By building a “Four-Core Full-Stack AI” ecosystem of EAI Brain and Developer Platform, EAI Devices, Industry Productivity Solutions and EAI Data Factory, FF aims to create an evolutionary flywheel: scaled device delivery, data collection and training, continuous evolution of the EAI Brain, stronger product capability, and even larger-scale delivery and deployment. Through this flywheel, FF seeks to maximize its commercial value and lead to the advancement of Physical AI. For more information, please visit Faraday Future’s official website: https://www.ff.com/
FFR Forward-Looking Statements
This communication, including any presentation, press release, investor materials or other document of which it forms a part (this “Communication”), contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws, regarding FF EAI Robotics Ecosystem Inc. (“FFR,” the “Company,” “us,” “our,” or “we”) and our industry. All statements, whether written or oral, other than statements of historical fact, including any financial projections and any statements regarding future events, our strategy, our transition to robotics operations, our plans for RoboShare, our digital asset disposition plans, the proposed acquisition of the FF EAI Robotics business, the projections referenced in this communication, our name and ticker change, any related financing, and the anticipated benefits and timing of the foregoing, our objectives, expectations, or anticipated actions or results, are forward-looking statements. You can often identify forward-looking statements by words such as “may,” “might,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” “likely,” or “continue,” or the negative of these terms or other similar expressions; the absence of these words does not mean a statement is not forward-looking. These statements reflect our current expectations and projections about future events as of the date of this Communication and are necessarily based on estimates and assumptions that, while considered reasonable by management, are inherently uncertain. FFR can give no assurance that such forward-looking statements or financial projections will prove to be correct.
Actual results may differ materially from those expressed or implied by these forward-looking statements as a result of numerous risks and uncertainties, both general and specific, including, but not limited to:
The proposed acquisition transaction and PIPE. The definitive agreements may be terminated in accordance with their terms, and the proposed transactions may not be completed on the terms described or at all; the conditions to closing, including the completion of FFAI’s internal restructuring of the robotics business, the execution of key employee agreements and other customary conditions, and the parties’ ability to satisfy them; the risk that the stockholder approval required under Nasdaq listing rules for the conversion of the preferred stock issued as consideration is not obtained or is delayed, and the effect of the conversion restrictions and the information statement process on the timing of conversion; the timing of the transaction and the costs of pursuing it; the issuance of a substantial number of shares as consideration and the resulting dilution to existing stockholders; the fact that the counterparty is our controlling stockholder, that it will hold a substantial majority of our outstanding shares following closing, that certain members of management serve both companies, and the conflicts of interest inherent in the transaction; the risk that the agreed valuations do not reflect the market value of our shares or of the acquired business; our dependence on the counterparty for transition, supply and support following any closing; the scope and enforceability of the non-competition and governance arrangements; the consequences of the transaction under Nasdaq listing rules, including the possibility that Nasdaq determines that the transaction requires us to satisfy initial listing requirements in connection with a business combination, change of control or change in the nature of our business; the risk that the PIPE financing, on which the transaction is not conditioned, is not completed on the anticipated terms or at all; the risk of litigation relating to the transaction; our ability to integrate and operate the acquired business; and the risk that the acquired business performs differently than anticipated.
Projections. The projections referenced in this communication were prepared by FFAI management for the FF EAI Robotics business on a standalone basis and do not reflect our existing business, transaction-related expenses or the combined company. We have not independently verified them or adopted them as guidance. They were not prepared with a view toward public disclosure or toward compliance with the published guidelines of the Securities and Exchange Commission or the American Institute of Certified Public Accountants regarding prospective financial information, and no independent registered public accounting firm has examined, compiled or performed any procedures with respect to them, and none expresses an opinion or any other form of assurance with respect to them. The projections reflect estimates and assumptions that are inherently uncertain and subject to change, including through due diligence and the review of our special committee and its financial advisor. Actual results are likely to differ, and may differ materially.
Liquidity, capital and going concern. Our limited cash and liquidity position and our history of operating losses and negative operating cash flow; substantial doubt regarding our ability to continue as a going concern, as described in our periodic reports; our need to obtain additional financing on acceptable terms or at all, and the substantial dilution to existing stockholders that additional financing may cause, including any financing completed in connection with the proposed transaction, which may not be completed or may be on less favorable terms than anticipated; our ability to fund operations pending and following the disposition of our digital asset positions; and our ability to satisfy the continued listing requirements of The Nasdaq Stock Market, including stockholders’ equity, minimum bid price and other applicable standards.
Our strategic transition and the disposition of digital assets. Risks associated with a fundamental shift in our business strategy and the redeployment of resources from a digital asset treasury strategy to robotics operations; our ability to execute the disposition of our digital asset positions in an orderly manner and on acceptable terms; the risk that amounts realized on disposition are materially less than carrying value as a result of price volatility, market depth, execution timing, custody or transfer constraints, or other limitations; tax, accounting and regulatory consequences of the dispositions; the continued volatility and regulatory uncertainty associated with digital assets and cryptocurrencies during the wind-down period; the concentration of a substantial portion of our assets in a single equity investment, including an investment in a related party, and the illiquidity, valuation uncertainty, holding-period and transfer restrictions associated with that investment; and risks arising from our relationships and agreements with related parties and significant stockholders.
Our robotics operations business. Our limited operating history in robotics operations and commercialization and the absence of a meaningful revenue history; the early stage of RoboShare and the risk that customer demand, repeat demand, pricing, utilization or unit economics do not develop as anticipated; our dependence on a small number of customers, on a single initial geographic market, and on individual events or engagements, and the risk that the loss of, or a change in the terms of, any such relationship has a disproportionate effect; our dependence on third-party robot owners, operators, suppliers, original equipment manufacturers and local partners, and on their willingness to make robots available on our platform; risks relating to the availability, cost, quality, maintenance, transport, insurance and technological obsolescence of robots and related equipment, and to supply chains, tariffs and trade measures affecting them; and our ability to expand into additional markets and to attract and retain participants on both sides of our marketplace.
Operations, safety and liability. Risks of property damage, personal injury or death arising from the operation of humanoid robots, quadrupeds and other autonomous or semi-autonomous machines in proximity to performers, employees, guests and the public, including at live events and in uncontrolled environments; product liability, premises liability, negligence and related claims and the adequacy, scope, availability and cost of our insurance coverage and of contractual indemnities from customers, owners and suppliers; the allocation of responsibility among us, robot owners, venues, event producers and customers; permitting, licensing, occupational safety and event-specific regulatory requirements; and the reputational consequences of any safety incident.
Technology, data and intellectual property. Systems, network, telecommunications or service disruptions, failures, defects or cyber-attacks; the performance, reliability and autonomy limitations of robotic systems and of the software, models and networks that support them; our collection, use, storage, transmission and protection of personal information, including images and any biometric or biometric-adjacent data captured in the course of robot deployments, and evolving privacy, biometric and artificial intelligence laws and regulations across the jurisdictions in which we operate or intend to operate; our ability to obtain, maintain, protect and enforce our intellectual property rights and to defend against third-party claims of infringement or misappropriation; and our reliance on third-party technology, platforms and licenses.
Legal, regulatory and general. The regulated industries and jurisdictions in which we operate; current or future laws or regulations and new interpretations of existing laws or regulations, including those applicable to digital assets, robotics, autonomous systems, consumer protection, advertising and endorsements; the risk that our marketplace arrangements, or the manner in which they are described, are characterized differently than we intend by regulators or courts; the failure of counterparties to perform their contractual obligations; litigation, regulatory inquiries, investigations and enforcement actions, and their costs and outcomes; business, economic, market and capital-market conditions; competition in our industry; changes in market demand for, and the pricing of, our products and services; our ability to define, design and release new products and services in a timely manner that meet customer needs; our ability to attract, retain and motivate qualified personnel, including key management; our ability to manage our growth and our transition; and our ability to maintain effective internal control over financial reporting and disclosure controls and procedures.
This list of factors is not exhaustive. Additional risks and uncertainties are described more fully in our filings with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2025, our Quarterly Reports on Form 10-Q, and our subsequent filings, which are available on the SEC’s website at www.sec.gov. Investors are urged to review the liquidity, capital resources and going concern disclosures contained in those reports.
The forward-looking statements in this Communication speak only as of the date hereof. Except as required by law, neither FFR nor any other person undertakes any obligation to update or revise any forward-looking statement or financial projection set out herein, whether as a result of new information, future events or otherwise. This Communication is provided for informational purposes only, does not constitute an offer to sell or the solicitation of an offer to buy any security, and does not constitute investment, tax or legal advice or any investment recommendation, and does not take into account the investment objectives or financial situation of any person. FFR reserves the right to amend or replace the information contained herein, in whole or in part, at any time, and undertakes no obligation to notify any recipient thereof. Readers are cautioned not to place undue reliance on these forward-looking statements. This caution is made under, and these forward-looking statements are intended to be covered by, the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.
FFAI FORWARD LOOKING STATEMENTS
Important factors that may affect actual results or outcomes include, among others: the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations, which it currently lacks; the availability of sufficient share capital to meet its current obligations and execute on its strategy; the willingness of convertible debt investors to fund the Company; demand for the Company’s robotics products; competition in the robotics industry, which includes companies with far superior experience, funding and name recognition; the ability of the Company to build an EAI education ecosystem that serves both the B2C consumer market and the B2B institutional education market; the acceptance by teachers and students of the Company’s robotics products in the education market; the ability of the Company to expand into additional markets for its robotics products; the Company’s reliance on a single OEM for most of its robotics products; the Company’s reliance on Chinese OEMs for all of its robotics products; the possibility of the federal government banning imports of Chinese robotics products; the Company’s ability to get the planned robotics products to comply with all applicable U.S. rules and regulations; the ability of the robotics OEM to timely supply robotics to the Company; tariff uncertainty for imported products, particularly from China; the ability of the Company to close its transaction with FF EAI Robotics Ecosystem Inc. (FFR) for the sale of its robotics business; demand from automobile dealers for robotics products; the Company’s ability to homologate FX vehicles for sale; the Company’s ability to secure the necessary funding to execute on the FX strategy, which is substantial; the Company’s ability to secure an occupancy certificate covering all of its Hanford facility; the Company’s ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of substantial losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s ability to execute on its plans to enter the robotaxi and cybercab industries; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company’s control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company’s operations in China; the success of the Company’s remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company’s ability to develop and protect its technologies; the Company’s ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings; the volatility of the Company’s stock price; the ability of the Company to maintain its stock price above $1.00; and the ability of the Company to maintain compliance with Nasdaq regulations for continued listing. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on August 13, 2026; the quarter ended March 31, 2026, filed with the SEC on May 14, 2026; and Form 10-K filed with the SEC on March 31, 2026, and other documents filed by the Company from time to time with the SEC.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ffr-to-hold-listing-ceremony-and-investor-day-on-october-26-ffai-announces-rescheduling-of-yt-jias-investor-weekly-report-to-october-26-302918891.html
SOURCE FF EAI Robotics Ecosystem Inc.
OASE+ and Elsevier Agree Next-Phase Read and Publish Agreement to Expand Open Access Publishing in Japan
uSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart
FFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia’s Investor Weekly Report to October 26
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology2 days agoMiami Startup BOB Raises $5.5M To Build An AI-Powered Banking Platform
-
Technology5 days agoWorkato Launches Self-Serve Platform in Singapore, Opening Enterprise AI to a Broader Community of Builders
-
Technology4 days agoVoqalize Says Voice Is Becoming the Default Way People Use Software
-
Technology5 days agoToku launches Makimoto Flows, a visual builder for speech AI pipelines, taking its open-source initiative beyond transcription
-
Technology4 days agoSnapmaker Introduces New Filament Bundle, Expanding Its Full Spectrum Printing Ecosystem
-
Technology5 days agoBlackpanda and CyberCube Collaborate to Bring Cyber Risk Analytics to Brokers Across Asia
-
Coin Market4 days agoBitcoin ETFs bag another $528M, taking 3-day haul past $1B
-
Technology4 days agoNew GASA Research: 71% of Adults Surveyed Across 13 Asian Markets Encountered Scams, with Estimated Losses of US$136.5 Billion
